BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Tubulis Technologies
/
Dr. Ingo Lehrke
DI
Dr. Ingo Lehrke
Chief Business Officer
Tubulis Technologies
Therapeutic Areas
Oncology
Tubulis Technologies Pipeline
Drug
Indication
Phase
TUB-040
Solid tumors (e.g., ovarian, NSCLC) targeting NaPi2b
Phase 1
TUB-030
Solid tumors targeting 5T4
Phase 1
Leadership Team at Tubulis Technologies
DD
Dr. Dominik Schumacher
Chief Executive Officer
DJ
Dr. Jonas Helma-Smets
Chief Scientific Officer
DC
Dr. Charles Fuchs
Chief Medical Officer
View full Tubulis Technologies profile